JCO
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
JCO
Jul 26, 2024, 00:16 |
Insight
Impact of the intratumoral microbiome of NSCLC on outcomes with immunotherapy
Stephen Liu shared on X: "Impressive work on impact of the intratumoral microbiome of NSCLC…
Jul 26, 2024, 00:03 |
Blog
Elisa Agostinetto: Must-read by Marleen Kok on the limitations of KEYNOTE-522
Elisa Agostinetto shared on X: "Out in JCO a must-read by Marleen Kok on the…
Jul 13, 2024, 22:16 |
Insight
Erman Akkus: Management of cancer-related fatigue - ASCO guideline
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X about a…
Jul 6, 2024, 12:24 |
Career
Omnia Korani: I have been accepted into the JCO Trainee Reviewer Mentoring Program
Omnia Korani, Assistant Lecturer at the National Cancer Institute, shared a post on LinkedIn: "Exciting…
Jul 5, 2024, 13:47 |
Insight
Andrea Apolo: Very proud of this Clinical Trial of Cabozantinib/Nivolumab published at JCO
Shilpa Gupta shared a post by Andrea Apolo, adding: "Huge congrats Andrea Apolo, leading this…
Jul 3, 2024, 22:59 |
Blog
Aleix Prat: Our 2 articles published this week
Aleix Prat, Head of the Medical Oncology Department at Hospital Clínic Barcelona, shared on X:…
Jul 3, 2024, 14:37 |
Insight
Jarushka Naidoo: Phase III RESILIENT Trial of Liposomal Irinotecan v Topotecan in 2L SCLC
Jarushka Naidoo shared a post on X: “Phase III RESILIENT Trial of Liposomal Irinotecan v…
Jul 1, 2024, 15:23 |
Insight
Paolo Tarantino: Final analysis of the ATEMPT phase 2 trial
Paolo Tarantino shared a post on X: “Can ADCs help prevent recurrence from breast cancer…
Jun 21, 2024, 14:36 |
Insight
High ORR and low CRS rate with Linvoseltamab for R/R Multiple Myeloma
Recently Jeffrey Zonder shared a post on X about a recent paper by Naresh Bumma…
Jun 21, 2024, 10:50 |
Blog
Out in JCO the groundbreaking results of the randomized phase 3 trial PALOMA-3 study
Antonio Passaro, Medical Oncologist at the European Institute of Oncology, shared on LinkedIn: "Out in…
May 16, 2024, 14:15 |
Insight
Elie G. Dib: Excited to share the results of the TAPUR study
Elie G. Dib, Associate Director of the Haematology-Oncology Training Program at Saint Joseph Mercy Hospital,…
May 12, 2024, 07:40 |
Insight
Yüksel Ürün: Excellent research on plasma Kidney Injury Molecule-1
Yüksel Ürün shared on X: "Congratulations to Wenxin Xu and the team for their excellent…
May 12, 2024, 04:15 |
Blog
Nico Gagelmann: Big achievement in JCO on timing of transplantation for patients with MDS
Nico Gagelmann, Chair of CAR-T for Plasma Cell Disorder Committee and Chair Trainee Committee at The…
May 9, 2024, 12:42 |
Blog
Estela Rodriguez: So much work to do to address barriers and develop pragmatic trials
Estela Rodriguez shared on X: “Only 7.1% of patients with cancer participate in clinical trials- so…
Apr 19, 2024, 15:52 |
Drugs
FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer based on ALINA trial
FDA, the Food and Drug Administration approved alectinib (Alecensa, Genentech, Inc.) for adjuvant treatment following…
Apr 8, 2024, 22:37 |
Insight
Key Message Highlights from Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma
Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous…
Mar 28, 2024, 02:31 |
Insight
Rami Manochakian: New Supportive Care Guideline by ASCO on Vaccination of adult with cancer
Rami Manochakian, Thoracic Medical Oncologist at Mayo Clinic, shared a post on X: "Hot off…
Mar 16, 2024, 10:45 |
Drugs
Vivek Subbiah: Exceptional Responses to Selpercatinib in RET Fusion–Driven Metastatic Pancreatic Cancer
Vivek Subbiah recently shared a post on X/Twitter: “Exceptional Responses to Selpercatinib in RET Fusion–Driven…
Mar 3, 2024, 17:26 |
Insight
Anjali Sibley: Let’s Harness the Healing Power - The Benefits of Exercise and Physical Activity During Cancer Treatment
Anjali Sibley, Clinical Associate Professor of Medicine at Stanford University School of Medicine, shared a…
Jan 29, 2024, 10:53 |
Insight
Paolo Tarantino: The highly debated results of PALOMA2 now published on JCO
Paolo Tarantino, Medical Oncologist, PhD Università degli Studi di Milano, Research Dana-Farber Cancer Institute, Harvard…
Dec 12, 2023, 11:42 |
Insight
Shruti Jolly: Treating lung cancer with immunotherapy and radiation without chemotherapy
Shruti Jolly, Associate Director for the Statewide Cancer Network at Michigan Medicine, shared on LinkedIn:…
May 28, 2023, 16:27 |
Opinion
As an oncology community we still have a lot to do, that more and more children do not need to go into the palliative care clinic and get cured - Gevorg Tamamyan
Quoting Gevorg Tamamyan on LinkedIn, "When people ask me, isn't it difficult to work as…
All:
22
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube